A Boston Scientific executive said that the company received FDA approval for its Farapoint pulsed field ablation (PFA) ...

Preliminary results from the FULCRUM-VT trial point to a safer, more effective way to treat ventricular tachycardia—a dangerous heart rhythm disorder that can lead to sudden cardiac arrest.

Pulse Biosciences Announces FDA IDE Approval to Initiate its nPulse Cardiac Catheter Ablation System Study for the Treatment of Atrial Fibrillation Pulse Biosciences, Inc. (Nasdaq: PLSE), a company ...

HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or ...

Edwards Lifesciences’ Sapien 3 valve with the Commander delivery system [Image courtesy of the company] The global, multibillion-dollar transcatheter heart valves market will grow at an 8.4% CAGR over ...